The biotech industry in the DACH region (Germany, Austria and Switzerland) is experiencing unprecedented growth, emerging as a hub of innovation and progress. A combination of robust funding, world-class research institutions, and unwavering government support drives this growth.
Our latest blog explores what makes the DACH region's biotech sector unique and why it presents a golden opportunity for biotech, pharma, and MedTech professionals.